Alex Kopelyan

Verified profile

Venture Capital, Private Equity Firm, Investor · United States

Alex Kopelyan is a venture capital investor and private equity investor based in the United States. They invest in Life Science, China Internet, Artificial Intelligence (AI) and Startups, typically at the Seed and Pre-Seed stage.

Investment stages

Industries

Similar investors in Life Science

  • Stacey Olson

    Venture Capital · United States

    Health CareWomen FoundedEnterprise SoftwareTransportation

    Portfolio: FreightWeb, Motherly

    Contact details available

  • Thomas Parkinson

    Venture Capital, Government Office, Private Equity Firm · United States

    Health CareTelecommunicationsAutonomous VehiclesCybersecurity

    Portfolio: Adrenaline Mobility, EarthSense, Inc.

    Contact details available

  • Meg EvansVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    SeedE-commerceEnterprise SoftwareCryptocurrencyLife Science

    Contact details available

  • Pantelis Georgiadis

    Venture Capital · United States

    AdvertisingHealth CareConsumer ResearchCybersecurity

    Portfolio: Insurance Noodle, Intelligencia

    Contact details available

  • Eric BednarskiVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics

    Contact details available

  • Alan Dahl

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedLife Science

    Portfolio: Unity Physician Partners, Peak Health Solutions

    Contact details available

  • Jeanette Welsh

    Venture Capital, Private Equity Firm, Angel/Individual · United States

    SeedHealth CareGeneticsAndroidChemical

    Portfolio: Precision NanoSystem, TrakCel

    Contact details available

  • Stephanie A. SirotaVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsEnterprise SoftwareInvestment Management

    Portfolio: AveXis, Frequency Therapeutics

    Contact details available